<DOC>
	<DOCNO>NCT03063515</DOCNO>
	<brief_summary>The investigator examine effect single dose pyridostigmine , AchE inhibitor insulin secretion healthy subject . Each subject undergo intravenous glucose tolerance test ( IVGTT ) IV glucose administer glucose excursion insulin secretion response evaluate measure insulin glucose different time point . The test carry twice , without administration single dose Pyridostigmine two separate day . The investigator hypothesize inhibit AChE potentiate insulin secretion .</brief_summary>
	<brief_title>AchE Inhibitor Insulin</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Pyridostigmine Bromide</mesh_term>
	<mesh_term>Cholinesterase Inhibitors</mesh_term>
	<criteria>18 year old BMI &gt; 30 Kg/m2 fast glucose &gt; 100 Hemoglobin A1C 5.7 % History asthma Use medication may interfere glucose metabolism</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Insulin secretion</keyword>
</DOC>